Reaction Details |
 | Report a problem with these data |
Target | Thrombin-activable fibrinolysis inhibitor (TAFIa) |
---|
Ligand | BDBM50135939 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_45639 |
---|
IC50 | 8.2±n/a nM |
---|
Citation | Barrow JC; Nantermet PG; Stauffer SR; Ngo PL; Steinbeiser MA; Mao SS; Carroll SS; Bailey C; Colussi D; Bosserman M; Burlein C; Cook JJ; Sitko G; Tiller PR; Miller-Stein CM; Rose M; McMasters DR; Vacca JP; Selnick HG Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithrombotics. J Med Chem 46:5294-7 (2003) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Thrombin-activable fibrinolysis inhibitor (TAFIa) |
---|
Name: | Carboxypeptidase B2 isoform A |
Synonyms: | CPB2 | CPU | Carboxypeptidase B2 | Carboxypeptidase B2 isoform A | Carboxypeptidase U | Plasma carboxypeptidase B | TAFI | Thrombin-activable fibrinolysis inhibitor | pCPB |
Type: | Enzyme |
Mol. Mass.: | 48432.74 |
Organism: | Homo sapiens (Human) |
Description: | Q96IY4 |
Residue: | 423 |
Sequence: | MKLCSLAVLVPIVLFCEQHVFAFQSGQVLAALPRTSRQVQVLQNLTTTYEIVLWQPVTAD
LIVKKKQVHFFVNASDVDNVKAHLNVSGIPCSVLLADVEDLIQQQISNDTVSPRASASYY
EQYHSLNEIYSWIEFITERHPDMLTKIHIGSSFEKYPLYVLKVSGKEQAAKNAIWIDCGI
HAREWISPAFCLWFIGHITQFYGIIGQYTNLLRLVDFYVMPVVNVDGYDYSWKKNRMWRK
NRSFYANNHCIGTDLNRNFASKHWCEEGASSSSCSETYCGLYPESEPEVKAVASFLRRNI
NQIKAYISMHSYSQHIVFPYSYTRSKSKDHEELSLVASEAVRAIEKISKNTRYTHGHGSE
TLYLAPGGGDDWIYDLGIKYSFTIELRDTGTYGFLLPERYIKPTCREAFAAVSKIAWHVI
RNV
|
|
|
BDBM50135939 |
---|
n/a |
---|
Name | BDBM50135939 |
Synonyms: | 3-(4,4-Diamino-but-3-enylsulfanyl)-2-mercaptomethyl-propionic acid | CHEMBL150332 |
Type | Small organic molecule |
Emp. Form. | C8H16N2O2S2 |
Mol. Mass. | 236.355 |
SMILES | NC(=N)CCCSCC(CS)C(O)=O |
Structure |
|